###BASE_URL###
2009-09-10 | permalink
A genetically modified bacterium that turns into a drug-delivery vehicle in the presence of a type of sugar may offer a new way to treat bowel disease, British scientists said on Friday. The new approach uses an engineered form of Bacteroides ovatus to deliver a human growth factor called KGF-2 directly to damaged cells in the gut -- but the process is only activated in the presence of xylan, a sugar that is rare in normal diet.
2009-09-10 | permalink
A genetically modified bacterium that turns into a drug-delivery vehicle in the presence of a type of sugar may offer a new way to treat bowel disease, British scientists said on Friday. The new approach uses an engineered form of Bacteroides ovatus to deliver a human growth factor called KGF-2 directly to damaged cells in the gut -- but the process is only activated in the presence of xylan, a sugar that is rare in normal diet.
GENET-news is providing a daily news service on a range of topics regarding genetic engineering. We are screening the worldwide English news, press releases and other publications to provide you with a strategic selection of information. GENET-news enables you to stay informed about all aspects of the global controversy around GE technologies and GE organisms. You can subscribe by email.
The GENET-forum list provides you with additional background information and more voluminous reports. It is only open for GENET members. Please contact the coordinator for membership and subscription.